BIODESIX, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
BIODESIX, INC. (BDSX) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $7.50 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-02-26
- BIODESIX, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $7.50M, a 25.00% increase from fiscal 2024.
- BIODESIX, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $6.00M, a 42.86% decline from fiscal 2023.
- BIODESIX, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $10.50M, a 30.46% decline from fiscal 2022.
- BIODESIX, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $15.10M, a 32.46% increase from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $7.50M 10-K · filed 2026-02-26 | |
| 2024-12-31 | $6.00M 10-K · filed 2026-02-26 | |
| 2023-12-31 | $10.50M 10-K · filed 2025-03-03 | |
| 2022-12-31 | $15.10M 10-K · filed 2024-03-01 | |
| 2021-12-31 | $11.40M 10-K · filed 2023-03-06 | |
| 2020-12-31 | $7.00M 10-K · filed 2022-03-14 | $4.90M 10-K · filed 2021-03-16 |
| 2019-12-31 | $7.00M 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |